Don't judge early-stage biotech Moderna on its stock's post-IPO drop: Cramer
December 10, 2018 at 18:35 PM EST
Jim Cramer says there's more to Wall Street newcomer Moderna than the action in the biotechnology company's stock.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|